In this landscape RSUME emerges as a VHL modulator: it is expressed in VHL syndrome tumors, interacts with VHL mutants and promotes HIF-2α stabilization by disruption of the VHL interactions. The gene discussed is EPAS1; the disease is von Hippel-Lindau disease.